SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,480,759 | -25.4% | 1,867,654 | 0.0% | 0.01% | -14.3% |
Q2 2023 | $8,684,591 | +0.6% | 1,867,654 | 0.0% | 0.01% | -12.5% |
Q1 2023 | $8,628,561 | -42.9% | 1,867,654 | -0.1% | 0.01% | -50.0% |
Q4 2022 | $15,098,409 | +45.6% | 1,868,615 | 0.0% | 0.02% | +45.5% |
Q3 2022 | $10,371,000 | +6.7% | 1,868,615 | +0.2% | 0.01% | +10.0% |
Q2 2022 | $9,717,000 | -36.7% | 1,865,180 | -0.2% | 0.01% | -9.1% |
Q1 2022 | $15,360,000 | -44.4% | 1,868,501 | +0.7% | 0.01% | -26.7% |
Q4 2021 | $27,606,000 | -18.6% | 1,855,250 | +3.4% | 0.02% | -16.7% |
Q3 2021 | $33,906,000 | +1.7% | 1,794,940 | +0.0% | 0.02% | +12.5% |
Q2 2021 | $33,354,000 | -13.6% | 1,794,173 | +5.8% | 0.02% | -27.3% |
Q1 2021 | $38,593,000 | +4.8% | 1,695,654 | 0.0% | 0.02% | +10.0% |
Q4 2020 | $36,813,000 | +116.0% | 1,695,654 | 0.0% | 0.02% | +66.7% |
Q3 2020 | $17,041,000 | +46.4% | 1,695,654 | +13.0% | 0.01% | +33.3% |
Q2 2020 | $11,640,000 | – | 1,500,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |